StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
222
This month
6
This week
1
This year
54
Today
1
Yesterday
1
Publishing Date
2024 - 03 - 29
2
2024 - 03 - 25
2
2024 - 03 - 22
2
2024 - 03 - 11
2
2024 - 03 - 08
2
2024 - 03 - 06
2
2024 - 02 - 29
2
2024 - 02 - 23
2
2024 - 02 - 15
2
2024 - 02 - 12
2
2024 - 02 - 02
2
2024 - 01 - 25
2
2024 - 01 - 17
2
2024 - 01 - 15
2
2024 - 01 - 03
2
2023 - 12 - 22
2
2023 - 10 - 23
2
2023 - 10 - 13
2
2023 - 10 - 10
2
2023 - 10 - 06
2
2023 - 10 - 05
2
2023 - 10 - 02
2
2023 - 09 - 11
2
2023 - 08 - 11
2
2023 - 07 - 28
2
2023 - 07 - 21
3
2023 - 07 - 14
3
2023 - 07 - 13
3
2023 - 05 - 09
2
2022 - 07 - 11
2
2022 - 05 - 16
2
2021 - 09 - 29
1
2021 - 09 - 23
1
2021 - 09 - 21
1
2021 - 09 - 15
1
2021 - 09 - 08
3
2021 - 09 - 03
4
2021 - 08 - 26
2
2021 - 08 - 23
1
2021 - 08 - 17
3
2021 - 08 - 12
1
2021 - 08 - 11
2
2021 - 08 - 03
1
2021 - 07 - 19
1
2021 - 07 - 13
1
2021 - 07 - 07
1
2021 - 07 - 06
1
2021 - 07 - 01
1
2021 - 06 - 04
1
2021 - 05 - 21
1
2021 - 05 - 19
1
2021 - 05 - 18
2
2021 - 05 - 11
1
2021 - 04 - 19
1
2021 - 04 - 09
1
2021 - 03 - 29
1
2021 - 03 - 17
1
2021 - 03 - 01
1
2021 - 02 - 16
1
2020 - 12 - 17
1
Sector
Commercial services
2
Communications
2
Consumer durables
1
Consumer non-durables
17
Consumer services
1
Electronic technology
3
Energy minerals
1
Finance
2
Health services
2
Health technology
222
Industrial services
1
Manufacturing
7
N/a
6
Process industries
4
Producer manufacturing
2
Retail trade
1
Tags
Acquisition
5
Approval
21
Approved
7
Astrazeneca
4
Biosimilar
2
Biotechnology
14
Cancer
6
Care
3
China
2
Conference
6
Contraceptive
3
Control
2
Cosentyx
2
Covid-19
3
Dental
2
Disease
3
Drug
13
Dupixent
4
Earnings
6
Europe
5
Ev
2
Events
3
Expected
6
Fda
90
Fda-approvals
30
Financial
7
Financial results
8
First
6
Food
6
For
4
Global
16
Growing
2
Growth
12
Health
4
Hypertension
3
Immunotherapy
2
Impact
2
Keytruda
4
Kids
2
Market
33
Merck
2
Merge
2
N/a
103
News
14
Nutrition
9
Opill
3
Pharma
5
Pharmaceutical
14
Rare
4
Regulatory
28
Report
14
Research
9
Results
17
Sanofi
3
Schizophrenia
3
Therapeutics
6
Therapy
5
Treatment
18
Week
4
Year
4
Entities
22nd century group, inc
1
3m company
1
Abbott laboratories
68
Abbvie inc.
2
Adamis pharmaceuticals corporation
1
Albemarle corporation
1
Alkermes plc
2
Allogene therapeutics, inc.
1
Altria group
1
Ardelyx, inc.
1
Arma services inc
1
Array technologies, inc.
1
Arrival
1
Astrazeneca plc
4
Athenex, inc.
1
Bausch health companies inc.
6
Baxter international inc.
2
Bellring brands, inc.
2
Biofrontera ag
1
Biogen inc.
1
Blockchain moon acquisition corp
1
Bristol-myers squibb company
2
Brown & brown, inc.
1
Campbell soup company
1
Capricor therapeutics, inc.
1
Catalent, inc.
1
Central garden & pet company
2
China petroleum & chemical corporation
1
Colgate-palmolive company
3
Csl ltd
1
Darden restaurants, inc.
1
Elanco animal health incorporated
3
Eli lilly and company
9
Endo international plc
3
Ericsson
1
Exxon mobil corporation
1
Gilead sciences, inc.
1
Glaxosmithkline plc
15
Goldman sachs group, inc. (the)
1
Heska corporation
1
Iaa, inc.
1
Johnson & johnson
99
Medies
2
Medtronic plc
2
Novartis ag
8
Orange
2
Perrigo company
222
Pfizer, inc.
2
Prestige consumer healthcare inc.
2
Psychemedics corporation
2
Reckitt benckiser group plc
6
Sanofi
111
Sol-gel technologies ltd.
3
Sonoma pharmaceuticals, inc.
2
Taro pharmaceutical industries ltd.
3
Teva pharmaceutical industries limited
2
Teva pharmaceutical industries ltd
6
The kraft heinz company
3
Viatris inc.
3
Zoetis inc.
5
Symbols
AAPL
546
ABB
1427
ABBV
1024
ABLZF
1166
ABT
1787
ACN
600
ARVL
586
BDX
796
BMO
539
BMY
662
BNPQF
654
BNPQY
654
BSX
575
CMI
542
CSCO
532
DELL
576
DHR
785
DOW
556
DUK
527
ERIC
545
F
641
FNCTF
1423
GE
917
GLAXF
657
GOOG
775
GOOGL
776
GSK
884
HON
1787
HUBS
1400
IBM
655
IT
594
JNJ
4583
LLY
1709
LMT
575
LYV
717
MDT
1285
MMM
938
MS
4286
MSFT
807
MT
589
NOC
589
NOK
901
NOKBF
904
NVO
632
NVS
1241
NVSEF
1031
ORCL
1158
PFE
692
PHG
962
SAP
1477
SAPGF
1231
SNOW
796
SNY
1630
SNYNF
1301
STLA
535
SYK
536
TMO
1623
TRU
533
VZ
1213
XYF
676
Exchanges
Amex
1
Nasdaq
151
Nyse
222
Crawled Date
2024 - 03 - 29
2
2024 - 03 - 25
2
2024 - 03 - 22
2
2024 - 03 - 11
2
2024 - 03 - 08
2
2024 - 03 - 06
2
2024 - 02 - 29
2
2024 - 02 - 23
2
2024 - 02 - 15
2
2024 - 02 - 12
2
2024 - 02 - 02
2
2024 - 01 - 25
2
2024 - 01 - 17
2
2024 - 01 - 15
2
2024 - 01 - 03
2
2023 - 12 - 22
2
2023 - 10 - 23
2
2023 - 10 - 13
2
2023 - 10 - 10
2
2023 - 10 - 06
2
2023 - 10 - 05
2
2023 - 10 - 02
2
2023 - 09 - 11
2
2023 - 08 - 11
2
2023 - 07 - 28
2
2023 - 07 - 21
3
2023 - 07 - 14
3
2023 - 07 - 13
3
2023 - 05 - 09
2
2022 - 07 - 11
2
2022 - 05 - 16
2
2021 - 09 - 30
1
2021 - 09 - 23
1
2021 - 09 - 21
1
2021 - 09 - 15
1
2021 - 09 - 08
3
2021 - 09 - 03
4
2021 - 08 - 26
2
2021 - 08 - 23
1
2021 - 08 - 17
3
2021 - 08 - 12
1
2021 - 08 - 11
2
2021 - 08 - 03
1
2021 - 07 - 19
1
2021 - 07 - 13
1
2021 - 07 - 07
1
2021 - 07 - 06
1
2021 - 07 - 01
1
2021 - 06 - 04
1
2021 - 05 - 21
1
2021 - 05 - 19
1
2021 - 05 - 18
2
2021 - 05 - 11
1
2021 - 04 - 19
1
2021 - 04 - 09
1
2021 - 03 - 29
1
2021 - 03 - 17
1
2021 - 03 - 01
1
2021 - 02 - 16
1
2020 - 12 - 17
1
Crawled Time
00:00
3
01:00
3
02:00
1
04:00
1
06:00
1
08:00
5
09:00
1
11:00
11
12:00
7
12:15
1
12:20
2
12:30
2
13:00
11
13:15
1
13:20
5
13:30
7
14:00
12
14:15
2
14:20
5
14:30
14
15:00
25
15:20
5
15:30
11
16:00
15
16:20
1
17:00
20
17:02
1
18:00
7
19:00
6
20:00
7
21:00
13
22:00
5
23:00
11
Source
www.biospace.com
119
www.fda.gov
2
www.globenewswire.com
6
www.prnewswire.com
95
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
PRGO
exchanges :
Nyse
save search
Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published:
2024-04-19
(Crawled : 15:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
0.0%
|
O:
-0.13%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
0.0%
|
O:
0.79%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
0.0%
|
O:
-0.75%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.0%
|
O:
0.82%
H:
0.0%
C:
0.0%
first
treatment
for
AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published:
2024-04-12
(Crawled : 14:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-3.96%
|
O:
-0.13%
H:
0.0%
C:
-2.94%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-3.82%
|
O:
-1.65%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.53%
|
O:
-1.06%
H:
0.21%
C:
-1.05%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.0%
|
O:
-3.02%
H:
0.0%
C:
0.0%
drug
label
astrazeneca
expansion
for
kids
Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published:
2024-04-08
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.01%
|
O:
2.24%
H:
0.0%
C:
-0.8%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-4.33%
|
O:
0.96%
H:
1.17%
C:
0.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.97%
|
O:
-0.48%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.32%
|
O:
0.09%
H:
0.16%
C:
-0.7%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.02%
|
O:
0.84%
H:
0.0%
C:
0.0%
for
FDA Greenlights New Antibiotic for SAB, Pneumonia
Published:
2024-04-05
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.54%
|
O:
-1.77%
H:
0.0%
C:
-1.81%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-4.48%
|
O:
-0.22%
H:
0.8%
C:
0.06%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.72%
|
O:
-1.84%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-3.37%
|
O:
-0.37%
H:
1.42%
C:
1.37%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.35%
|
O:
-3.44%
H:
0.0%
C:
0.0%
fda
for
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published:
2024-04-03
(Crawled : 13:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-4.09%
|
O:
-0.29%
H:
1.34%
C:
-0.64%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.1%
|
O:
0.02%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.02%
|
O:
0.11%
H:
0.37%
C:
-0.77%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.59%
|
O:
0.69%
H:
0.0%
C:
0.0%
fda
drug
schizophrenia
AstraZeneca Kicks Off April With New PNH Approval
Published:
2024-04-02
(Crawled : 13:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-6.45%
|
O:
-1.09%
H:
0.13%
C:
-1.39%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.13%
|
O:
-0.77%
H:
0.8%
C:
0.74%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.08%
|
O:
-0.18%
H:
0.47%
C:
0.12%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.67%
|
O:
-1.14%
H:
0.02%
C:
-1.06%
approval
astrazeneca
FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published:
2024-03-29
(Crawled : 19:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
fda
hepatitis
kidney
anemia
Global Immune Health Supplements Outlook Report 2023-2029: Vendors Focus on Advancements and Quality, Creating Competition by Offering Innovative Solutions
Published:
2024-03-29
(Crawled : 11:00)
- prnewswire.com
BRBR
|
$53.98
-0.46%
0.0%
990K
|
Health Technology
|
Email alert
Add to watchlist
MEDE
|
News
|
$0.51
0%
500
|
n/a
|
Email alert
Add to watchlist
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
report
health
offering
global
solutions
FDA Approves New Treatments for Two Rare Diseases
Published:
2024-03-27
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.26%
|
O:
-0.26%
H:
0.0%
C:
0.0%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-2.47%
|
O:
0.84%
H:
1.48%
C:
1.29%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.86%
|
O:
0.3%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-3.65%
|
O:
1.48%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-7.5%
|
O:
1.06%
H:
0.0%
C:
0.0%
fda
rare
IONETIX announces appointment of Douglas Boothe to Board of Directors
Published:
2024-03-26
(Crawled : 11:00)
- prnewswire.com
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-3.13%
|
O:
0.48%
H:
0.0%
C:
-1.16%
Regeneron Hit With Two CRLs, J&J’s PAH Treatment Approved
Published:
2024-03-25
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.09%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-4.09%
|
O:
0.35%
H:
0.35%
C:
-1.34%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.82%
|
O:
0.04%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-3.77%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.33%
|
O:
0.42%
H:
0.0%
C:
0.0%
approved
treatment
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
Published:
2024-03-25
(Crawled : 12:00)
- globenewswire.com
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-4.09%
|
O:
0.35%
H:
0.35%
C:
-1.34%
ARDX
|
$6.5
0.93%
0.92%
5.6M
|
Health Technology
|
-16.36%
|
O:
-0.13%
H:
2.02%
C:
0.13%
biopharma
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nods for DMD, Hypertension
Published:
2024-03-22
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.65%
|
O:
-1.58%
H:
0.0%
C:
0.0%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-4.88%
|
O:
0.35%
H:
0.99%
C:
-1.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.81%
|
O:
0.02%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.0%
|
O:
-0.43%
H:
0.41%
C:
-0.85%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.11%
|
O:
1.47%
H:
0.23%
C:
-0.19%
fda
hypertension
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nod for DMD, Hypertension
Published:
2024-03-22
(Crawled : 14:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.65%
|
O:
-1.58%
H:
0.0%
C:
0.0%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-4.88%
|
O:
0.35%
H:
0.99%
C:
-1.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.81%
|
O:
0.02%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.0%
|
O:
-0.43%
H:
0.41%
C:
-0.85%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.11%
|
O:
1.47%
H:
0.23%
C:
-0.19%
fda
hypertension
FDA Approves Takeda’s Iclusig for Type of Leukemia, Idorsia’s Hypertension Drug
Published:
2024-03-21
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.29%
|
O:
0.14%
H:
0.24%
C:
0.24%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-4.03%
|
O:
0.0%
H:
1.6%
C:
0.89%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.83%
|
O:
-0.03%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.53%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.83%
|
O:
0.3%
H:
0.0%
C:
0.0%
fda
drug
iclusig
hypertension
FDA Approves First Gene Therapy for Rare Pediatric Disease
Published:
2024-03-18
(Crawled : 23:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-1.09%
|
O:
0.33%
H:
0.13%
C:
-1.51%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.4%
|
O:
0.2%
H:
0.08%
C:
-1.14%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-6.18%
|
O:
1.71%
H:
0.36%
C:
-2.52%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.01%
|
O:
-0.81%
H:
0.0%
C:
0.0%
fda
rare
first
disease
therapy
Madrigal’s Rezdiffra, BMS’s Breyanzi Lead Week of Landmark FDA Approvals
Published:
2024-03-15
(Crawled : 15:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-2.69%
|
O:
-0.62%
H:
0.59%
C:
-1.01%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.85%
|
O:
-1.58%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-11.37%
|
O:
-5.53%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.03%
|
O:
-0.02%
H:
0.0%
C:
0.0%
fda
breyanzi
week
FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug ...
Published:
2024-03-11
(Crawled : 17:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-0.69%
|
O:
0.0%
H:
2.38%
C:
1.12%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.8%
|
O:
0.43%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-11.91%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.31%
|
O:
0.57%
H:
0.0%
C:
0.0%
fda
drug
wegovy
approved
FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug Rejected
Published:
2024-03-11
(Crawled : 14:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-0.69%
|
O:
0.0%
H:
2.38%
C:
1.12%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.8%
|
O:
0.43%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-11.91%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.31%
|
O:
0.57%
H:
0.0%
C:
0.0%
fda
drug
wegovy
approved
FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa
Published:
2024-03-08
(Crawled : 18:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
1.18%
|
O:
0.98%
H:
3.17%
C:
0.9%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.42%
|
O:
-0.68%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-11.4%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.38%
|
O:
-0.08%
H:
0.0%
C:
0.0%
fda
brukinsa
approval
← Previous
1
2
3
4
5
6
7
8
9
10
11
12
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.